648 related articles for article (PubMed ID: 28286190)
1. Outcome of adults with Eisenmenger syndrome treated with drugs specific to pulmonary arterial hypertension: A French multicentre study.
Hascoet S; Fournier E; Jaïs X; Le Gloan L; Dauphin C; Houeijeh A; Godart F; Iriart X; Richard A; Radojevic J; Amedro P; Bosser G; Souletie N; Bernard Y; Moceri P; Bouvaist H; Mauran P; Barre E; Basquin A; Karsenty C; Bonnet D; Iserin L; Sitbon O; Petit J; Fadel E; Humbert M; Ladouceur M
Arch Cardiovasc Dis; 2017 May; 110(5):303-316. PubMed ID: 28286190
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes of pulmonary arterial hypertension under specific drug therapy in Eisenmenger syndrome.
Hascoët S; Baruteau AE; Humbert M; Simonneau G; Jais X; Petit J; Laux D; Sitbon O; Lambert V; Capderou A
J Heart Lung Transplant; 2017 Apr; 36(4):386-398. PubMed ID: 27866929
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Macitentan in Patients With Eisenmenger Syndrome.
Gatzoulis MA; Landzberg M; Beghetti M; Berger RM; Efficace M; Gesang S; He J; Papadakis K; Pulido T; Galiè N;
Circulation; 2019 Jan; 139(1):51-63. PubMed ID: 30586694
[TBL] [Abstract][Full Text] [Related]
4. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
[No Abstract] [Full Text] [Related]
5. Prognosis and response to first-line single and combination therapy in pulmonary arterial hypertension.
Kylhammar D; Persson L; Hesselstrand R; Rådegran G
Scand Cardiovasc J; 2014 Aug; 48(4):223-33. PubMed ID: 24912571
[TBL] [Abstract][Full Text] [Related]
6. What is the position of pulmonary arterial hypertension-specific drug therapy in patients with Eisenmenger syndrome: A systematic review and meta-analysis.
Li Q; Kuang HY; Wu YH; Lu TW; Yi QJ
Medicine (Baltimore); 2019 May; 98(20):e15632. PubMed ID: 31096477
[TBL] [Abstract][Full Text] [Related]
7. A retrospective study of bosentan in pulmonary arterial hypertension associated with congenital heart disease.
Durongpisitkul K; Jakrapanichakul D; Sompradikul S
J Med Assoc Thai; 2008 Feb; 91(2):196-202. PubMed ID: 18389984
[TBL] [Abstract][Full Text] [Related]
8. High-sensitivity troponin T is associated with poor outcome in adults with pulmonary arterial hypertension due to congenital heart disease.
Schuuring MJ; van Riel AC; Vis JC; Duffels MG; van Straalen JP; Boekholdt SM; Tijssen JG; Mulder BJ; Bouma BJ
Congenit Heart Dis; 2013; 8(6):520-6. PubMed ID: 23241414
[TBL] [Abstract][Full Text] [Related]
9. Eisenmenger syndrome a clinical perspective in a new therapeutic era of pulmonary arterial hypertension.
Beghetti M; Galiè N
J Am Coll Cardiol; 2009 Mar; 53(9):733-40. PubMed ID: 19245962
[TBL] [Abstract][Full Text] [Related]
10. Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups.
Manes A; Palazzini M; Leci E; Bacchi Reggiani ML; Branzi A; Galiè N
Eur Heart J; 2014 Mar; 35(11):716-24. PubMed ID: 23455361
[TBL] [Abstract][Full Text] [Related]
11. Cardiac remodelling amongst adults with various aetiologies of pulmonary arterial hypertension including Eisenmenger syndrome-implications on survival and the role of right ventricular transverse strain.
Moceri P; Bouvier P; Baudouy D; Dimopoulos K; Cerboni P; Wort SJ; Doyen D; Schouver ED; Gibelin P; Senior R; Gatzoulis MA; Ferrari E; Li W
Eur Heart J Cardiovasc Imaging; 2017 Nov; 18(11):1262-1270. PubMed ID: 28011668
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary vasoreactivity predicts long-term outcome in patients with Eisenmenger syndrome receiving bosentan therapy.
D'Alto M; Romeo E; Argiento P; Santoro G; Sarubbi B; Gaio G; Mélot C; Russo MG; Naeije R; Calabrò R
Heart; 2010 Sep; 96(18):1475-9. PubMed ID: 20668108
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary arterial hypertension associated with a congenital heart defect: advanced medium-term medical treatment stabilizes clinical condition.
Duffels M; van Loon L; Berger R; Boonstra A; Vonk-Noordegraaf A; Mulder B
Congenit Heart Dis; 2007; 2(4):242-9. PubMed ID: 18377475
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of surgery for chronic thromboembolic pulmonary hypertension compared with medical therapy at a single Korean center.
Kim SH; Lee JW; Ahn JM; Kim DH; Song JM; Lee SD; Lee JS
Korean J Intern Med; 2017 Sep; 32(5):855-864. PubMed ID: 27733022
[TBL] [Abstract][Full Text] [Related]
15. Contemporary survival of patients with pulmonary arterial hypertension and congenital systemic to pulmonary shunts.
Vijarnsorn C; Durongpisitkul K; Chungsomprasong P; Bositthipichet D; Ketsara S; Titaram Y; Chanthong P; Kanjanauthai S; Soongswang J
PLoS One; 2018; 13(4):e0195092. PubMed ID: 29664959
[TBL] [Abstract][Full Text] [Related]
16. Endothelin receptor antagonists improve exercise tolerance and oxygen saturations in patients with Eisenmenger syndrome and congenital heart defects.
Mehta PK; Simpson L; Lee EK; Lyle TA; McConnell ME; Book WM
Tex Heart Inst J; 2008; 35(3):256-61. PubMed ID: 18941642
[TBL] [Abstract][Full Text] [Related]
17. Speckle-tracking imaging in patients with Eisenmenger syndrome.
Moceri P; Iriart X; Bouvier P; Baudouy D; Gibelin P; Saady R; Laïk J; Cerboni P; Thambo JB; Ferrari E
Arch Cardiovasc Dis; 2016 Feb; 109(2):104-12. PubMed ID: 26868160
[TBL] [Abstract][Full Text] [Related]
18. [Pulmonary arterial hypertension in patients with congenital heart disease: current issues and health care situation].
Kaemmerer H; Gorenflo M; Hoeper M; Huscher D; Ewert P; Pittrow D
Dtsch Med Wochenschr; 2013 Jun; 138(23):1247-52. PubMed ID: 23720182
[TBL] [Abstract][Full Text] [Related]
19. Eisenmenger syndrome in the adult--experience with new drugs for the treatment of pulmonary hypertension.
Agapito AF; Sousa L; Oliveira JA; Feliciano J; Cacela D; Quininha J
Rev Port Cardiol; 2005 Mar; 24(3):421-31. PubMed ID: 15929625
[TBL] [Abstract][Full Text] [Related]
20. Impaired Right, Left, or Biventricular Function and Resting Oxygen Saturation Are Associated With Mortality in Eisenmenger Syndrome: A Clinical and Cardiovascular Magnetic Resonance Study.
Jensen AS; Broberg CS; Rydman R; Diller GP; Li W; Dimopoulos K; Wort SJ; Pennell DJ; Gatzoulis MA; Babu-Narayan SV
Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26659374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
